Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 107

Related Citations for PubMed (Select 22910293)

1.

Thymidine kinase suicide gene-mediated ganciclovir ablation of autologous gene-modified rhesus hematopoiesis.

Barese CN, Krouse AE, Metzger ME, King CA, Traversari C, Marini FC, Donahue RE, Dunbar CE.

Mol Ther. 2012 Oct;20(10):1932-43. doi: 10.1038/mt.2012.166. Epub 2012 Aug 21.

2.

Lentiviral vector conferring resistance to mycophenolate mofetil and sensitivity to ganciclovir for in vivo T-cell selection.

Sangiolo D, Lesnikova M, Nash RA, Jensen MC, Nikitine A, Kiem HP, Georges GE.

Gene Ther. 2007 Nov;14(21):1549-54. Epub 2007 Sep 6.

PMID:
17805303
3.

In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.

Okada T, Caplen NJ, Ramsey WJ, Onodera M, Shimazaki K, Nomoto T, Ajalli R, Wildner O, Morris J, Kume A, Hamada H, Blaese RM, Ozawa K.

J Gene Med. 2004 Mar;6(3):288-99.

PMID:
15026990
4.

Herpes simplex virus thymidine kinase and ganciclovir suicide gene therapy for human pancreatic cancer.

Wang J, Lu XX, Chen DZ, Li SF, Zhang LS.

World J Gastroenterol. 2004 Feb 1;10(3):400-3.

5.

In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats.

Ram Z, Culver KW, Walbridge S, Blaese RM, Oldfield EH.

Cancer Res. 1993 Jan 1;53(1):83-8.

6.
7.

Retrovirus-mediated transfer of a suicide gene into lens epithelial cells in vitro and in an experimental model of posterior capsule opacification.

Couderc BC, de Neuville S, Douin-Echinard V, Serres B, Manenti S, Darbon JM, Malecaze F.

Curr Eye Res. 1999 Dec;19(6):472-82.

PMID:
10550788
8.

Adenovirus-mediated gene transfer of enhanced Herpes simplex virus thymidine kinase mutants improves prodrug-mediated tumor cell killing.

Wiewrodt R, Amin K, Kiefer M, Jovanovic VP, Kapoor V, Force S, Chang M, Lanuti M, Black ME, Kaiser LR, Albelda SM.

Cancer Gene Ther. 2003 May;10(5):353-64.

PMID:
12719705
9.

Experimental study of the RV-HSV-TK/GCV suicide gene therapy system in gastric cancer.

Tang Q, Zhang D, Wan M, Jin L.

Cancer Biother Radiopharm. 2007 Dec;22(6):755-61.

PMID:
18158766
11.

VSV-G pseudotyped, MuLV-based, semi-replication-competent retrovirus for cancer treatment.

Qiao J, Moreno J, Sanchez-Perez L, Kottke T, Thompson J, Caruso M, Diaz RM, Vile R.

Gene Ther. 2006 Oct;13(20):1457-70. Epub 2006 May 25.

PMID:
16724095
12.

TK.007: A novel, codon-optimized HSVtk(A168H) mutant for suicide gene therapy.

Preuss E, Treschow A, Newrzela S, BrĂ¼cher D, Weber K, Felldin U, Alici E, Gahrton G, von Laer D, Dilber MS, Fehse B.

Hum Gene Ther. 2010 Aug;21(8):929-41. doi: 10.1089/hum.2009.042.

PMID:
20201626
13.

HSV vector cytotoxicity is inversely correlated with effective TK/GCV suicide gene therapy of rat gliosarcoma.

Moriuchi S, Krisky DM, Marconi PC, Tamura M, Shimizu K, Yoshimine T, Cohen JB, Glorioso JC.

Gene Ther. 2000 Sep;7(17):1483-90.

14.

Conditional negative selection of gene-modified hematopoietic stem cells.

Baum C.

Mol Ther. 2012 Oct;20(10):1841-2. doi: 10.1038/mt.2012.195. No abstract available.

15.
17.

[Effects of retrovirus-mediated HSV-tk/GCV on human hepatocellular carcinoma].

Zhao Y, Zhang X, Hui H.

Zhonghua Gan Zang Bing Za Zhi. 1999 Jun;7(2):113-5. Chinese.

PMID:
10488424
18.

HSV-TK/GCV cancer suicide gene therapy by a designed recombinant multifunctional vector.

Wang Y, Canine BF, Hatefi A.

Nanomedicine. 2011 Apr;7(2):193-200. doi: 10.1016/j.nano.2010.08.003. Epub 2010 Oct 1.

20.

T cell transduction and suicide with an enhanced mutant thymidine kinase.

Qasim W, Thrasher AJ, Buddle J, Kinnon C, Black ME, Gaspar HB.

Gene Ther. 2002 Jun;9(12):824-7.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk